Purchase Order 75N91024P00623
Award Date
9/1/24
Potential Completion Date
8/31/29
Potential Value
$649K
Federal Agency
National Cancer Institute
Awardee
Expression Manufacturing LLC
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hamilton, OH 45011, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation...
This firm fixed-price contract for $803,500.00 was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Vector Biomed Inc. for the production and stability testing of clinical grade lentiviral vector. The services include manufacturing a minimum of 50mg of GMP/clinical grade transfer plasmid and 400ml of concentrated, GMP grade lentiviral vector, as well as performing stability testing...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Lentigen Technology, Inc. for the manufacture of a good manufacturing practice (GMP) lot of a lentiviral vector encoding a CD19/CD22 targeting bispecific chimeric antigen receptor (CD19/CD22 BiCAR) gene for clinical use. The contract has a ceiling value of $322,000.00 and a completion date of August 7, 2017. The contract was awarded on August 8, 2016 and was not set aside...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) to Lentigen Technology, Inc., a for-profit organization, for the manufacture of a Good Manufacturing Practice (GMP) lot of a lentiviral vector encoding a chimeric antigen receptor (CAR) targeting CD22. The contract, valued at $205,000.00, is for the production of this vector to support an ongoing clinical trial...
This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the prime contractor Aldevron, L.L.C., a for-profit limited liability company that manufactures biologics. The contract is for the production and purification of custom DNA plasmids, specifically 600 mg of pM766 gp160 V1, 40 mg of pSW M766 gp120 V1, and 600 mg of SIV p57 Gag custom plasmids, to support ongoing research...
This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, to Vector Biosystems, Inc. (doing business as Vector Biolabs), a for-profit biotechnology company that provides gene delivery products and services. The $16,120 contract is for the delivery of an AAV viral vector with an EF1a promotor expressing a green fluorescent protein. This contract supports NCATS' biomedical...
This federal contract award, valued at $10,600.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The contract was awarded to Vector Biosystems, Inc., doing business as Vector Biolabs, a minority-owned, small disadvantaged biotechnology company that provides gene delivery products and services. The contract is for the delivery of an AAV8-SPC512-MCHERRY construct, which is likely a gene...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order to Sirion Biotech GMBH, a foreign-owned for-profit company, for the delivery of LENTIBOOST formulated, good manufacturing practice (GMP)-grade lentiviral products. The $21,000 contract is to support gene therapy research and patient treatments conducted by the NIH Clinical Center. The award does not include any set-aside designation or subcontractors....
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed price purchase order to Sirion Biotech GmbH, a foreign-owned for-profit organization, for the delivery of LENTIBOOST formulated, GMP-grade viral vector products. The order, valued at $21,000.00, supported gene therapy research and patient treatments conducted by the NIH Clinical Center. The contract did not have any set-aside designations and Sirion Biotech delivered the requested viral...
<p>The National Heart Lung and Blood Institute (NHLBI) awarded a $611,500.00 firm fixed-price purchase order contract to Vector Biomed Inc. for the production of a lentiviral vector, CX170. This contract, which does not have a set-aside designation, has a completion date of September 2, 2027. The place of performance is in NO POTOMAC, MD 20878, USA.</p>